Details of the Drug Reposition

General Information of This Drug (ID: DMF89ZT)

Drug Name	SEP-228432 DMF89ZT

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Depression	DIS3XJ69	6A70-6A7Z	Phase 1	[1]
Neuropathic pain	DISC905E	8E43.0	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01531972) A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects. U.S. National Institutes of Health.